[1]祁梅,顾志荣,杨浩,等.基于临床用药与社会学视角探讨中药用药风险的原因与防控对策[J].西部中医药,2023,36(09):55-59.[doi:10.12174/j.issn.2096-9600.2023.09.12]
　QI Mei,GU Zhirong,YANG Hao,et al.Discussion on the Causes, Prevention and Control Countermeasures of the Risks of Traditional Chinese Medicine Based on Clinical Medication and Sociological Perspectives[J].Western Journal of Traditional Chinese Medicine,2023,36(09):55-59.[doi:10.12174/j.issn.2096-9600.2023.09.12]
点击复制

基于临床用药与社会学视角探讨中药用药风险的原因与防控对策
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年09期
页码:
55-59
栏目:
出版日期:
2023-09-15

文章信息/Info

Title:
Discussion on the Causes, Prevention and Control Countermeasures of the Risks of Traditional Chinese Medicine Based on Clinical Medication and Sociological Perspectives
作者:
祁梅1, 顾志荣2, 杨浩2, 陈红宁1, 葛斌1
1.甘肃省人民医院药剂科，甘肃 兰州 730000
2.甘肃中医药大学药学院，甘肃 兰州 730000
Author(s):
QI Mei1, GU Zhirong2, YANG Hao2, CHEN Hongning1, GE Bin1
1.Department of Pharmacy, Gansu Provincial Hospital, Lanzhou 730000, China
2.College of Pharmacy, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
关键词:
中药; 临床用药; 用药风险; 风险防控; 社会舆论
Keywords:
traditional Chinese medicine; clinical application; medication risks; risk prevention and control; public opinion
分类号:
R288
DOI:
10.12174/j.issn.2096-9600.2023.09.12
文献标志码:
A
摘要:
目的从临床用药与社会学视角探讨中药用药风险的原因与防控对策。 方法收集临床及社会上有关中药用药风险的典型案例，探讨中药用药风险原因，并提出相应防控对策。 结果中药用药风险的主要原因包括中药用药相关指南与共识建设不足，忽视中药用药警戒，临床中不严格甚至不辨证使用中药，无适应证及随意超适应证使用中药，根据偶见报道的现代药理作用随意选用中药，不合理联合使用中药，中药注射剂滴速及溶媒控制不严格，主要药味、功效主治相同或相近的中成药、汤剂、中药注射剂重复使用，以及社会舆论的非正确导向与传播等。建议进一步倡导遵守国家相关政策规定，强化中药合理使用相关政策规定与临床指南建设，构建基于临床大数据及循证医学证据的适合西医医师使用的常见疾病辨证用药数据库/手册、常见中药注射剂与中成药辨证使用数据库/手册等，建立特殊中药精准分级管理模式，加大中药安全合理使用相关科普力度与广度，积极干预医师根据偶见报道的现代药理作用随意选用中药，加强中药用药风险评价体系、预警机制及相关平台建设。 结论中药用药风险的原因涉及临床用药与社会学两个层面，应在两个层面同时加强警惕并积极合理干预。
Abstract:
ObjectiveTo explore the cause and the countermeasures of preventing and controlling the risk of traditional Chinese medicine based on clinical medication and sociological perspectives. MethodsTypical clinical cases and social ones about the risk of TCM were gathered to discuss the causes of the risk of TCM, and put forward the corresponding prevention and control measures. ResultsThe main reasons of the risk of TCM contained the lack of the guidelines and consensus on the use of TCM, neglecting herbal medication vigilance, casual herbal administration even medication without syndrome differentiation, medication without the corresponding indications or beyond the indications casually, arbitrary use of TCM based on occasionally reported modern pharmacological effects, unreasonable combination use of herbs, non-strict control of drip rate and solvent of TCM injection, repeated use of Chinese patent medicine, decoction and TCM injections with the same or similar Chinese herbs and efficacy, incorrect orientation and transmission of public opinions. Therefore, we recommend further advocating for compliance with relevant national policies and regulations, strengthening the construction of the relevant policies and regulations of rational use of herbs and clinical guidelines, building the database/manual for syndrome differentiation and medications of the common diseases based on clinical big data and evidence-based medicine suitable for physicians of Western medicine, the database/handbook for syndrome differentiation and the application of common herbal injections and Chinese patent medicine and others, establishing the precise hierarchical management mode of special TCM, increasing the strength and breadth of science popularization related to the safe and rational uses of TCM, actively intervened the doctors’ random choice of TCM based on occasional reports of modern pharmacological effects, strengthening the construction of risk evaluation system of TCM, early warning mechanisms and the related platform for TCM. ConclusionThe causes for TCM use risks involve clinical medication and sociology, and we should strengthen vigilance and intervene at both levels actively and reasonably.

相似文献/References:

[1]赵中玮.中药命名规律分析[J].西部中医药,2012,25(10):29.
　ZHAO Zhong-wei.Analysis on Rules of Naming of Herbs[J].Western Journal of Traditional Chinese Medicine,2012,25(09):29.
[2]杨 峰,邓 强,朱焕平,等.钩活术配合中药热敷治疗颈椎病182例[J].西部中医药,2012,25(10):93.
　YANG Feng,DENG Qiang,ZHU Huan-ping,et al.Clinical Observation of 182 Cases of Cervical Spondylosis Treated with Entice Hook and Herbal Hot Compress[J].Western Journal of Traditional Chinese Medicine,2012,25(09):93.
[3]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121.
　PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(09):121.
[4]向林华.中药联合必可酮雾化吸入治疗小儿咳嗽变异性哮喘30例临床观察[J].西部中医药,2013,26(03):97.
　XIANG Linhua.Clinical Observation on Treatment for 30 Cases of Infantile Cough Variant Asthma with Herbs and Atomized Becotide Spray for Inhalation[J].Western Journal of Traditional Chinese Medicine,2013,26(09):97.
[5]张民.细菌耐药背景下的中药抗菌作用探析[J].西部中医药,2013,26(06):122.
　ZHANG Min.Exploration on TCM Antibiosis under the Background of Bacterial Resistance[J].Western Journal of Traditional Chinese Medicine,2013,26(09):122.
[6]姜玲艳,刘高宏,黄清杰.大孔吸附树脂在分离纯化中药有效成分中的应用[J].西部中医药,2013,26(06):125.
　JIANG Lingyan,LIU Gaohong,HUANG Qingjie.Application of Macroporous Adsorptive Resins to the Separation and Purification of Active Ingredients of Herbs[J].Western Journal of Traditional Chinese Medicine,2013,26(09):125.
[7]赵道洲,郑恒恒△,李兴国.通络搽剂治疗软组织损伤的主要药效学研究*[J].西部中医药,2012,25(09):8.
　ZHAO Dao-zhou,ZHENG Heng-heng,LI Xing-guo.Pharmacodynamics of TongLuo ChaJi in Treating Soft Tissue Injury[J].Western Journal of Traditional Chinese Medicine,2012,25(09):8.
[8]姚世雄,李杰.拉米夫定初始联合阿德福韦酯及中药治疗慢性乙型肝炎30例效果观察[J].西部中医药,2012,25(09):66.
　YAO Shi-xiong,LI Jie.Lamivudine Initially Combined with Adefovir Dipivoxil and Herbs in Treating 30 Cases of Chronic Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2012,25(09):66.
[9]李军,乔淑琴,吴国强.中药辅助治疗视网膜脱离术后视网膜下积液的临床疗效观察[J].西部中医药,2013,26(10):87.
　LI Jun,QIAO Shuqin,WU Guoqiang.Observation on Supplementary Therapy for Subretinal Dropsy after the Surgery of Retinal Detachment with TCM[J].Western Journal of Traditional Chinese Medicine,2013,26(09):87.
[10]何桂英,李培华.双腔气囊导尿管在中药保留灌肠中的应用[J].西部中医药,2013,26(08):107.
　HE Guiying,LI Peihua.Application of Dual Chamber Aerocyst Catheter to Retention Enema with Herb[J].Western Journal of Traditional Chinese Medicine,2013,26(09):107.

备注/Memo

备注/Memo:
祁梅（1968—），女，副主任药师。研究方向：制剂研发。甘肃省中医药管理局科研项目（GZK-2019-41）；甘肃省人民医院研发攻关项目（18GSSY2-3）
更新日期/Last Update: 2023-09-15